Transforming Health Through the Power of Psychedelics
Rose Hill Life Sciences is committed to leading research in psychedelics.
We focus on how psilocybin can benefit mental health. We partner with top scientists and institutions to find new treatments using psilocybin. Our modern labs and passionate team help us conduct important studies and trials. We aim to share our findings with the scientific community and improve mental health care for everyone.
As Seen On
What We Do
We Supply Psilocybin and Conduct Key Research.
Research and Analytics
Rose Hill Life Sciences is a research-driven team of scientists, clinicians, and mycologists advancing psilocybin through clinical trials and data-backed innovation. We study all aspects of Psilocybe cubensis, with a focus on alkaloid profiles and their impact on therapeutic outcomes. Our mission is to produce high-quality, research-grade psilocybin while upholding the highest standards in safety and scientific rigor.
Cultivation and Supply
We cultivate and supply a wide variety of psilocybin biomass. Our extensive genetic library allows us to offer diverse products. This variety helps us meet the specific needs of each partner. We aim to provide the best products for their research or brand.
Unique Genetics
We are on a mission to build a diverse genetic library of psilocybin. This gives us a strong advantage as we grow in the US and Canada. Our team constantly works to find new varieties and methods. This helps keep our genetic library of high quality and suited to market needs. We believe that a wide genetic library is key to staying ahead in this fast-changing industry.
Clinical Trials
Rose Hill Life Sciences partners with leading research institutions and organizations to support the clinical development of psilocybin-based therapies. Our role spans from supplying high-quality, research-grade Psilocybe cubensis to contributing expertise in formulation, genetics, and data analysis.
Blog
Access our blog for the latest updates and awareness on psychedelics.
In The Media